Suchergebnisse - "Back, David J"

PubPharm (226)

61

Detection of Drug Bioactivation in Vivo: Mechanism of Nevirapine–Albumin Conjugate Formation in Patients

enthalten in: Chemical research in toxicology | 2013

von Meng, X. | Howarth, A. | Earnshaw, C. | +5

62

Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment

enthalten in: AIDS (London, England) | 2013

von Lamorde, M. | Byakika-Kibwika, P. | Mayito, J. | +7

63

Non-disclosure of HIV status in UK sexual health clinics--a pilot study to identify non-disclosure within a national unlinked anonymous seroprevalence survey

enthalten in: Sexually transmitted infections | 2013

von Sullivan, A. | Savage, E. | Lowndes, C. | +5

64

Non-disclosure of HIV status in UK sexual health clinicsa pilot study to identify non-disclosure within a national unlinked anonymous seroprevalence survey

enthalten in: Sexually transmitted infections | 2013

von Sullivan, A. | Savage, E. | Lowndes, C. | +5

65

Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings : a consensus statement

enthalten in: The Lancet. Infectious diseases | 2012

von Crawford, K. | Ripin, D. | Levin, A. | +46

66

Divalent metals and pH alter raltegravir disposition in vitro

enthalten in: Antimicrobial agents and chemotherapy | 2012

von Moss, D. | Siccardi, M. | Murphy, M. | +4

67

Divalent Metals and pH Alter Raltegravir Disposition In Vitro

enthalten in: Antimicrobial agents and chemotherapy | 2012

von Moss, D. | Siccardi, M. | Murphy, M. | +4

68

Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical setting

enthalten in: Therapeutic drug monitoring | 2012

von Siccardi, M. | DʼAvolio, A. | Rodriguez-Novoa, S. | +10

69

Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers : results of the ENCORE 2 study

enthalten in: Antimicrobial agents and chemotherapy | 2012

von Else, L. | Jackson, A. | Puls, R. | +11

70

Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study

enthalten in: Antimicrobial agents and chemotherapy | 2012

von Else, L. | Jackson, A. | Puls, R. | +11